We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Elec Geo(DI) | LSE:EGI | London | Ordinary Share | COM STK USD0.001 (DI) |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 102.50 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Electrical Geodesics, Inc. (London AIM: EGI.L, “EGI” or the “Company”), a leading neurodiagnostic medical technology company, today announces its unaudited interim results for the six months ended 30 June 2016 (H1 2016).
Financial Highlights
Operating Highlights
Don Tucker, CEO of EGI, commented: “We believe that dense-array EEG (dEEG) has gained a firm foothold in our core research markets. With this growing visibility we expect to see improving acceptance of dEEG in the much larger clinical markets for neurodiagnostics and pre-surgical planning where our source localization technology can play an important role.” He added: “We expect that our research customers will assess the applicability of GTEN and GS3 across a broad range of indications that will highlight the potential of these technologies in the larger clinical markets both in diagnosis and treatment of important neurological conditions.”
This announcement contains inside information as defined in Article 7 of the Market Abuse Regulation No 596/2014 and is disclosed in accordance with the Company's obligation under Article 17 of those Regulations.
This announcement contains “forward looking statements” that involve substantial risk and uncertainties. These statements relate to future events or our future financial performance or condition and involve known and unknown risks, uncertainties and other factors that could cause our actual results, levels of activity, performance or achievement to differ materially from those expressed or implied by these forward looking statements.
About Electrical Geodesics, Inc.
Founded in 1992, EGI designs, develops and commercialises a range of non-invasive neurodiagnostic and neuromodulation products used to monitor, interpret and modulate brain activity, based on its proprietary dense array electroencephalography ("dEEG") platform technology. The Company's technology uses up to 256 sensors, providing much higher resolution brain activity data compared to conventional 8 or 16 channel EEG and is used in medical, clinical and research settings in a diverse range of applications including important areas such as the diagnosis and monitoring of epilepsy, neurosurgical planning, sleep assessment, and many others. The Company's products are compatible with multiple diagnostic and imaging technologies, including magnetic resonance imaging (MRI), functional MRI (fMRI), and magneto-encephalography (MEG).
View source version on businesswire.com: http://www.businesswire.com/news/home/20160829006081/en/
EGIAnn Bunnenberg+1 541-687-7962abunnenberg@egi.comwww.egi.comorPeel Hunt LLP (NOMAD and Broker)James Steel or Oliver Jackson+44 (0) 20 7418 8900
1 Year Elec Geo(DI) Chart |
1 Month Elec Geo(DI) Chart |
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions